How is the advent of adjuvant therapy in NSCLC changing our approach to surgery?

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options. The multidisciplinary team Medical oncologist: Dr David Planchard, France  Pulmonologist: Prof. Johan Vansteenkiste, Belgium Thoracic surgeon: Dr Masahiro Tsuboi, Japan This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/